Pharmacyclics completes direct public offering

Pharmacyclics Inc. (NASDAQ: PCYC), Sunnyvale, Calif. Business: Cancer, Autoimmune Date completed: 6/17/11 Type: Direct public offering Raised: $57.1 million Shares: 6.4 million Price: $8.85 Shares aft...